Heart Test Laboratories Inc. (HSCS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 3.41 |
Market Cap | 3.33M |
Revenue (ttm) | 15.71 |
Net Income (ttm) | -8.15K |
EPS (ttm) | 5.35 |
PE Ratio (ttm) | 0.64 |
Forward PE | -0.46 |
Analyst | Buy |
Ask | 3.5 |
Volume | 5,501 |
Avg. Volume (20D) | 37,336 |
Open | 3.43 |
Previous Close | 3.36 |
Day's Range | 3.37 - 3.44 |
52-Week Range | 2.36 - 18.50 |
Beta | 3.29 |
About HSCS
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake...
Analyst Forecast
According to 2 analyst ratings, the average rating for HSCS stock is "Buy." The 12-month stock price forecast is $13.5, which is an increase of 297.06% from the latest price.